{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:54:08Z","timestamp":1790913248747,"version":"4.1.0"},"reference-count":32,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunohistochemical (IHC) features of clear cell renal cell carcinomas (CCRCC) have historically been defined by morphologically selected tumours, but aberrant staining patterns that may confound the diagnosis are common. Recent studies have described the prognostic significance of architectural patterns in CCRCC and have proposed grading schemes based on morphology. We investigate a cohort of molecularly verified CCRCC to evaluate their IHC profiles and correlate with architectural patterns and key driver molecular alterations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Renal cell carcinomas (RCCs) sequenced at our institution between January 2015 and June 2024 by NGS assay were reviewed to identify CCRCCs based on\n                      <jats:italic>VHL<\/jats:italic>\n                      alterations and\/or 3p loss. Architectural patterns were classified into low grade (LG) (nested, cystic), intermediate grade (IG) (tubular, tubulopapillary, alveolar), and high grade (HG) (fused nests\/solid sheets, rhabdoid, sarcomatoid, low\u2010grade spindled, pleomorphic tumour giant cells), based on findings from recent studies and scored based on highest\u2010grade pattern. IHC staining for CA9, KER7, PAX8, and CD10 were reviewed for percent staining (focal 25% or less, moderate 26%\u201350%, diffuse greater than 50%). Correlation of aberrant staining with primary\/metastatic status, architectural patterns, and molecular alterations was analysed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      125 cases of molecularly verified CCRCC were identified and 108 cases with concurrent IHC met inclusion criteria, including 54 primary and 54 metastatic tumours. KER7 positivity was more common in primary vs. metastatic tumours (45% vs. 13%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001), in tumours with LG\/IG architectural patterns (67% LG and 67% IG vs. 17% HG,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002) and in\n                      <jats:italic>PBRM1<\/jats:italic>\n                      wild type (WT) tumours (84%\n                      <jats:italic>PBRM1<\/jats:italic>\n                      WT vs. 16%\n                      <jats:italic>PBRM1<\/jats:italic>\n                      mutated,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.021). Negative CA9 staining occurred only in metastatic tumours (15%).\n                      <jats:italic>PBRM1<\/jats:italic>\n                      mutated tumours were more likely to be KER7\u2010\/CA9+\/PAX8\u2010, while\n                      <jats:italic>BAP1<\/jats:italic>\n                      mutated tumours were more likely to have higher\u2010grade architectural patterns and lack CD10 expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this cohort of molecularly verified CCRCCS, positive KER7 staining was seen in 30% of tumours with diffuse strong staining in 16%. The IHC profiles correlated with both morphological features and genetic alterations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/his.70287","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:11:02Z","timestamp":1790910662000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunohistochemical profile of molecularly verified clear cell renal cell carcinomas"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0825-186X","authenticated-orcid":false,"given":"Kara S.","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Pathology University of California San Francisco  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics University of California San Francisco  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9047-0222","authenticated-orcid":false,"given":"Chien\u2010Kuang Cornelia","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Pathology University of California San Francisco  San Francisco California USA"},{"name":"Department of Urology University of California San Francisco  San Francisco California USA"},{"name":"UCSF Helen Diller Family Comprehensive Cancer Center University of California San Francisco  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1783-1711","authenticated-orcid":false,"given":"Nancy Y.","family":"Greenland","sequence":"additional","affiliation":[{"name":"Department of Pathology University of California San Francisco  San Francisco California USA"},{"name":"UCSF Helen Diller Family Comprehensive Cancer Center University of California San Francisco  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffry P.","family":"Simko","sequence":"additional","affiliation":[{"name":"Department of Pathology University of California San Francisco  San Francisco California USA"},{"name":"Department of Urology University of California San Francisco  San Francisco California USA"},{"name":"UCSF Helen Diller Family Comprehensive Cancer Center University of California San Francisco  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5836-2624","authenticated-orcid":false,"given":"Bradley A.","family":"Stohr","sequence":"additional","affiliation":[{"name":"Department of Pathology University of California San Francisco  San Francisco California USA"},{"name":"UCSF Helen Diller Family Comprehensive Cancer Center University of California San Francisco  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0848-4172","authenticated-orcid":false,"given":"Deepika","family":"Sirohi","sequence":"additional","affiliation":[{"name":"Department of Pathology University of California San Francisco  San Francisco California USA"},{"name":"UCSF Helen Diller Family Comprehensive Cancer Center University of California San Francisco  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"e_1_2_11_2_1","volume-title":"Urinary and male genital tumours","author":"WHO Classification of Tumours Editorial Board","year":"2022"},{"key":"e_1_2_11_3_1","unstructured":"NCCN Guidelines Kidney Cancer Version 3.2025."},{"key":"e_1_2_11_4_1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.52733\/KCJ18n3-a1","article-title":"What morphology can teach us about renal cell carcinoma clonal evolution","volume":"18","author":"Kapur P","year":"2020","journal-title":"Kidney Cancer J."},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.10.052"},{"key":"e_1_2_11_6_1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41379-021-00982-9","article-title":"Development and validation of a vascularity\u2010based architectural classification for clear cell renal cell carcinoma: Correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes","volume":"35","author":"Ohe C","year":"2022","journal-title":"Mod. Pathol."},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2022.01.005"},{"key":"e_1_2_11_8_1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PAS.0000000000001025","article-title":"Architectural patterns are a relevant morphologic grading system for clear cell renal cell carcinoma prognosis assessment: Comparisons with WHO\/ISUP grade and integrated staging systems","volume":"42","author":"Verine J","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.03.043"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318299f0fb"},{"key":"e_1_2_11_11_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humpath.2022.07.022","article-title":"The expanding role of BAP1 in clear cell renal cell carcinoma","volume":"133","author":"Kapur P","year":"2023","journal-title":"Hum. Pathol."},{"key":"e_1_2_11_12_1","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: The genitourinary pathology society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov K","year":"2021","journal-title":"Mod. Pathol."},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001476"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000631"},{"key":"e_1_2_11_15_1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PAS.0000000000001422","article-title":"\u201cRenal cell carcinoma with Leiomyomatous stroma\u201d harbor somatic mutations of TSC1, TSC2, MTOR, and\/or ELOC (TCEB1): Clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity","volume":"44","author":"Shah RB","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2022.12.015"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100777"},{"key":"e_1_2_11_18_1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/his.13791","article-title":"Reactivity of CK7 across the spectrum of renal cell carcinomas with clear cells","volume":"74","author":"Gonzalez ML","year":"2019","journal-title":"Histopathology"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.5858\/2007-131-1290-IAOCRC"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-003-0948-2"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000163362.78475.63"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31825b37f0"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-4-21"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0839-y"},{"key":"e_1_2_11_25_1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.euf.2015.11.007","article-title":"Correlation between molecular subclassifications of clear cell renal cell carcinoma and targeted therapy response","volume":"2","author":"Ho TH","year":"2016","journal-title":"Eur. Urol. Focus"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/10668969231157317"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12222"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505917"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.03.075"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqaa176"},{"key":"e_1_2_11_31_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2022.10.009","article-title":"Deciphering intratumor heterogeneity in clear cell renal cell carcinoma utilizing clinicopathologic and molecular platforms","volume":"130","author":"Vormittag\u2010Nocito E","year":"2022","journal-title":"Hum. Pathol."},{"key":"e_1_2_11_32_1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13073-025-01504-x","article-title":"MorphoITH: A framework for deconvolving intra\u2010tumor heterogeneity using tissue morphology","volume":"17","author":"Nielsen AW","year":"2025","journal-title":"Genome Med."},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-2318"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/his.70287","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/his.70287","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/his.70287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:11:06Z","timestamp":1790910666000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/his.70287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":32,"alternative-id":["10.1111\/his.70287"],"URL":"https:\/\/doi.org\/10.1111\/his.70287","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"2026-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"his.70287"}}